• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Biosurgery Market

    ID: MRFR/MED/55277-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    US Biosurgery Market Research Report By Product Type (Surgical Sealants, Hemostats, Tissue Adhesives, Bone Grafts, Wound Closure Products), By Application (Cardiac Surgery, Orthopedic Surgery, Neurosurgery, General Surgery, Plastic and Reconstructive Surgery), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and By Distribution Channel (Direct Sales, Distributors, Online Sales) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Biosurgery Market Infographic

    US Biosurgery Market Summary

    The US Biosurgery market is projected to grow from 2.5 USD billion in 2024 to 4.5 USD billion by 2035.

    Key Market Trends & Highlights

    US Biosurgery Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 5.49 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 4.5 USD billion, indicating robust growth potential.
    • In 2024, the market is valued at 2.5 USD billion, reflecting a solid foundation for future expansion.
    • Growing adoption of innovative surgical techniques due to increasing demand for minimally invasive procedures is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.5 (USD Billion)
    2035 Market Size 4.5 (USD Billion)
    CAGR (2025-2035) 5.49%

    Major Players

    Organogenesis, Acelity, Smith & Nephew, Halyard Health, Integra LifeSciences, 3M, Braun Melsungen, L. Gore & Associates, Baxter International, Stryker Corporation, Covalon Technologies, Boston Scientific, Zimed, Medtronic, Johnson & Johnson

    US Biosurgery Market Trends

    The US Biosurgery Market is experiencing significant growth driven by several key factors. Increasing surgical procedures, especially in areas like orthopedics, cardiology, and general surgery, are pushing demand for biosurgical products. The rise in chronic diseases among the US population, along with an aging demographic, is creating a greater need for surgical interventions, directly impacting the biosurgery market. Furthermore, advancements in biotechnology and regenerative medicine are enhancing the development and application of biosurgical products, fueling innovation within the sector.

    Additionally, the emphasis on minimally invasive surgical techniques has increased the adoption of biosurgical solutions that improve recovery times and reduce patient pain, contributing further to market expansion.Opportunities are ripe for exploration in the realm of biosurgery, particularly in the development of new products emphasizing biocompatibility and biodegradability. As healthcare providers focus on personalized medicine, biosurgical products that can be tailored to individual patient needs are likely to gain traction. Collaboration between biotech firms and medical institutions is essential, as it can lead to breakthroughs in surgical adhesives and hemostatic agents.

    There is also potential for the enhancement of training programs for healthcare providers on the effective use of biosurgical products, which could result in improved patient outcomes and promote market growth.Recent trends in the US market indicate an increasing shift towards innovative technologies, such as the incorporation of artificial intelligence in surgical procedures and the development of smart biosurgery products that provide real-time feedback during surgeries. The US government is also supporting these advancements through funding initiatives for research in biosurgery and associated technologies.

    Overall, the US Biosurgery Market is at a pivotal point, demonstrating notable trends that favor growth and innovation.

    Market Segment Insights

    Biosurgery Market Product Type Insights  

    The Product Type segment of the US Biosurgery Market is integral to addressing various surgical needs, showcasing diverse categories such as Surgical Sealants, Hemostats, Tissue Adhesives, Bone Grafts, and Wound Closure Products. Surgical Sealants are increasingly recognized for their capability to quickly and effectively seal wounds during surgeries, reducing the risk of complications and promoting faster healing, which makes them vital in modern surgical procedures.

    Hemostats play a crucial role in controlling bleeding, a common concern across numerous surgical disciplines, thus becoming essential tools in blood management during surgeries.Tissue Adhesives offer a minimally invasive alternative for wound closure, aligning with the trend towards less invasive procedures in the healthcare sector, providing quicker recovery times and lower infection rates compared to traditional suturing methods. Bone Grafts are especially important in orthopedic surgeries and procedures involving bone regeneration, addressing critical issues in surgeries related to trauma, degenerative diseases, or reconstructive surgeries, thus enhancing the success rates of these operations.

    Wound Closure Products are fundamental in various surgical applications, providing reliable solutions to ensure effective closure and healing of incisions and traumatic wounds.Overall, the diverse Product Type offerings within the US Biosurgery Market are driven by technological advancements, the increasing volume of surgical procedures, and a growing emphasis on patient outcomes, generating significant interest and investment in this sector. The rise in outpatient surgery and minimally invasive techniques further underscores the importance of these products in improving surgical efficiency, safety, and postoperative recovery times in the competitive landscape of the US medical industry.

    As the healthcare sector evolves, these segments are poised to adapt, providing innovative solutions to meet the ever-changing needs of healthcare providers and patients alike.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Biosurgery Market Application Insights  

    The Application segment of the US Biosurgery Market showcases vital components that cater to various surgical needs. As the market evolves, significant emphasis is placed on Cardiac Surgery, where biosurgical interventions play a crucial role in streamlining cardiac procedures and enhancing patient safety. Orthopedic Surgery is also notable, as advances in biosurgical techniques support quicker recovery times and improved patient outcomes in this high-demand area. Neurosurgery benefits from these innovative solutions, focusing on reducing complications and enhancing surgical precision.Furthermore, General Surgery continues to leverage biosurgery innovations, reflecting a growing preference for minimally invasive procedures that ensure patient comfort.

    Lastly, Plastic and Reconstructive Surgery utilizes biosurgical products to facilitate complex repairs and aesthetic enhancements, showcasing its significant contribution to cosmetic healthcare. Trends in patient preferences, such as an increased demand for safer, more effective surgical options, are driving the growth in these applications within the US Biosurgery Market. Overall, these applications are essential as they respond to specific healthcare demands, promoting advancements across diverse surgical practices.

    Biosurgery Market End User Insights  

    The End User segment of the US Biosurgery Market plays a crucial role in the overall growth and adoption of biosurgical products. Hospitals, being the primary setting for advanced surgical procedures, significantly contribute to the market due to their extensive infrastructure and resources. The increasing complexity of surgeries and the rising prevalence of chronic diseases fuel the demand for innovative biosurgical solutions within these institutions.

    Ambulatory Surgical Centers (ASCs) present another vital sector that is gaining traction as they offer cost-effective and efficient surgical options, appealing to both patients and healthcare providers.This sector is experiencing growth driven by a shift towards outpatient procedures, underscoring its importance in the market landscape. Specialty Clinics, on the other hand, cater to specific patient needs, focusing on areas such as orthopedics or wound care. This specialization allows for targeted applications of biosurgical products, highlighting their significance in improving patient outcomes.

    Overall, the segmentation of the US Biosurgery Market by End User illustrates diverse opportunities and challenges influenced by various healthcare trends, including the need for minimally invasive solutions and enhanced patient care.

    Biosurgery Market Distribution Channel Insights  

    The Distribution Channel of the US Biosurgery Market plays a crucial role in ensuring that innovative surgical products reach healthcare providers effectively. In recent years, Direct Sales have become a vital component, as manufacturers are directly engaging with hospitals and clinics to provide customized solutions and training. Distributors also significantly contribute to the market by offering extensive networks that enable broader product accessibility across various regions, thereby enhancing the reach of biosurgery technologies.

    Online Sales are emerging as an essential channel due to the increasing shift towards digitalization in healthcare; this avenue allows healthcare professionals to easily access supplies and information while also facilitating quicker order fulfillment.The diversification of Distribution Channels in the US Biosurgery Market reflects the industry's response to the changing demands for efficient delivery mechanisms, fostering competition and innovation. As the market evolves, these channels will continue to adapt to emerging trends, including the integration of advanced technology and the focus on improving patient outcomes.

    With a rapidly growing population requiring sophisticated surgical solutions, the significance of these Distribution Channels cannot be understated in addressing the diverse needs within the US healthcare system.

    Get more detailed insights about US Biosurgery Market

    Key Players and Competitive Insights

    The competitive landscape of the US Biosurgery Market is marked by rapid innovation and a growing emphasis on enhanced patient outcomes. As advancements in surgical techniques and technology continue to evolve, the market has seen an influx of new players alongside established entities. This dynamic environment is characterized by significant investment in research and development, fostering a range of biosurgical products that cater to varied medical needs, such as wound care, tissue repair, and regenerative medicine.

    Companies are increasingly focusing on developing bioactive materials and solutions that can alleviate healing times and improve surgical efficacy, resulting in a competitive marketplace where product differentiation, regulatory compliance, and cost-effectiveness play critical roles.Organogenesis has firmly established its presence within the US Biosurgery Market, leveraging its extensive portfolio of biosurgery and regenerative medicine products. Key strengths of Organogenesis include its innovative approach to wound care and surgical reconstruction, positioning it as a leader in the development of advanced biologics. The company's focus on providing comprehensive solutions that promote healing and recovery has resulted in strong brand recognition among healthcare professionals.

    Moreover, the strategic emphasis on collaborations with healthcare institutions and continuous investment in clinical research further solidifies its competitive edge. Organogenesis is committed to addressing the needs of healthcare providers and patients with a robust pipeline of products that prioritize efficiency and healing outcomes.Acelity has emerged as a leading player in the US Biosurgery Market, emphasizing advanced wound care and regenerative medicine solutions. The company has developed a broad range of key products and services, including advanced dressings and tissue regeneration technologies, catering primarily to surgical and chronic wound indications.

    Acelity's strengths lie in its innovative research and development initiatives, which have led to groundbreaking products with proven clinical benefits. In recent years, Acelity has expanded its market presence through strategic mergers and acquisitions, allowing for synergistic growth and enhancing its capabilities in providing comprehensive biosurgical solutions. This strategic approach not only strengthens its competitive positioning but also enhances its capacity to serve diverse patient needs effectively, further entrenching Acelity's influence in the US biosurgery sector.

    Key Companies in the US Biosurgery Market market include

    Industry Developments

    The US Biosurgery Market has seen significant developments recently, primarily driven by advancements in wound care and surgical procedures. In September 2023, Organogenesis announced the expansion of its advanced wound care portfolio, focusing on regenerative medicine, which reflects the growing emphasis on biologics. Acelity has also made strides in the sector by enhancing its KCI product line aimed at improving patient outcomes through innovative therapies.

    In terms of acquisitions, Smith and Nephew acquired a minority stake in a leading digital health company in August 2023, aiming to integrate digital solutions into wound care. The market valuation of companies like Integra LifeSciences and 3M has also seen growth owing to increasing investments in Research and Development directed toward biosurgery solutions. In recent years, significant developments include Medtronic’s collaboration with various healthcare institutions to streamline surgical procedures and Johnson and Johnson’s efforts to introduce new surgical tools to the market.

    This growth is also supported by increasing governmental funding for healthcare technologies aimed at enhancing surgical outcomes across the US. Overall, the US Biosurgery Market continues to evolve rapidly, driven by innovation and strategic investments by leading companies.

    Market Segmentation

    Biosurgery Market End User Outlook

    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics

    Biosurgery Market Application Outlook

    • Cardiac Surgery
    • Orthopedic Surgery
    • Neurosurgery
    • General Surgery
    • Plastic and Reconstructive Surgery

    Biosurgery Market Product Type Outlook

    • Surgical Sealants
    • Hemostats
    • Tissue Adhesives
    • Bone Grafts
    • Wound Closure Products

    Biosurgery Market Distribution Channel Outlook

    • Direct Sales
    • Distributors
    • Online Sales

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 2.31(USD Billion)
    Market Size 2024 2.5(USD Billion)
    Market Size 2035 4.5(USD Billion)
    Compound Annual Growth Rate (CAGR) 5.489% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019 - 2023
    Market Forecast Units USD Billion
    Key Companies Profiled Organogenesis, Acelity, Smith & Nephew, Halyard Health, Integra LifeSciences, 3M, B. Braun Melsungen, W.L. Gore & Associates, Baxter International, Stryker Corporation, Covalon Technologies, Boston Scientific, Zimed, Medtronic, Johnson & Johnson
    Segments Covered Product Type, Application, End User, Distribution Channel
    Key Market Opportunities Increasing demand for minimally invasive surgeries, Growing prevalence of chronic diseases, Advancements in biotechnology and materials, Expanding applications in orthopedic surgeries, Rising investments in regenerative medicine
    Key Market Dynamics growing geriatric population, increasing surgical procedures, technological advancements in products, rising prevalence of chronic diseases, enhanced healthcare expenditure
    Countries Covered US

    Leave a Comment

    FAQs

    What is the expected market size of the US Biosurgery Market in 2024?

    The US Biosurgery Market is expected to be valued at 2.5 billion USD in 2024.

    What is the forecasted market valuation for the US Biosurgery Market by 2035?

    By 2035, the US Biosurgery Market is projected to reach a valuation of 4.5 billion USD.

    What is the expected CAGR for the US Biosurgery Market between 2025 and 2035?

    The expected CAGR for the US Biosurgery Market from 2025 to 2035 is 5.489%.

    Which product type is predicted to maintain the largest market share in 2024 within the US Biosurgery Market?

    Surgical Sealants are projected to have the largest market share, valued at 0.568 billion USD in 2024.

    What will be the market size for Hemostats in the US Biosurgery Market by 2035?

    The market size for Hemostats is expected to grow to 0.802 billion USD by 2035.

    Who are some of the key players in the US Biosurgery Market?

    Major players in the US Biosurgery Market include Organogenesis, Acelity, and Smith & Nephew.

    What is the projected market size for Wound Closure Products in 2035?

    Wound Closure Products are anticipated to reach a market size of 1.326 billion USD in 2035.

    What growth opportunity exists in the Bone Grafts segment of the US Biosurgery Market?

    The Bone Grafts segment is forecasted to grow from 0.455 billion USD in 2024 to 0.733 billion USD by 2035.

    What challenges might affect the growth of the US Biosurgery Market?

    Factors such as regulatory hurdles and competition could present challenges to the market's growth.

    How are current global economic conditions affecting the US Biosurgery Market?

    Global economic conditions may influence supply chains and pricing strategies in the US Biosurgery Market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions